INTRODUCTION
============

Inflammation is usually considered a beneficial event which helps to heighten the immune response initiated following tissue injury or infection. Molecular alarm signals generated from the damaged tissues or invading pathogens are recognized by antigen-presenting cells (APCs) such as macrophages. Macrophages are key players in innate immunity and respond rapidly to danger signals generated from inflamed sites. Recognition of these danger signals through specific cell surface pattern recognition receptors (PRRs) on macrophages results in the production of anti-microbial products as well as pro-inflammatory mediators ([@B13]; [@B20]).

Inflammation is a tightly regulated process with production of alarm signals sharply diminishing after the pathogens or cellular debris have been eliminated and tissue homeostasis restored. Many "stop signals" at appropriate checkpoints prevent further leukocyte infiltration into tissues if they are no longer needed ([@B66]). If the balance between inflammation and resolution becomes dysregulated, excess macrophage responses will lead to chronic inflammation, and resultant disease states, which include atherosclerosis, rheumatoid arthritis (RA), asthma ([@B54]), and cancer ([@B22]). Therefore, understanding the regulation of inflammation and its resolution could help in the development of new therapeutic approaches for inflammatory disease management.

Macrophages are optimally activated by a combination of two macromolecular signals in their environment: antigen recognition by PRPs and IFN-γ ([@B52]; [@B56]) and produce pro-inflammatory cytokines, TNF-α, IL-6, and IL-1β. These pro-inflammatory cytokines are important pyrogens capable of inducing the formation of the fever response and elevation of body temperature through complex neurological and behavioral changes ([@B39],[@B40]; [@B9]; [@B45]; [@B63], [@B62]). Fever is a highly conserved phenomenon in evolution ([@B36], [@B38]; [@B48]; [@B24]). Although numerous human and animal studies reveal a positive correlation between the febrile response and a better survival rate, the mechanism by which increased core temperature improves host defense is still not clear. In addition, new studies suggest additional levels of complex interaction between macrophage function and body temperature. [@B55] have shown that exposure to a cold environment induces alternative activation of adipose tissue macrophages. Thus, while it is likely that their function is responsive to thermal signals, the specific mechanisms by which macrophages sense and respond to temperature change in a way that specifically regulates their function has not been clarified.

To investigate the effect of febrile temperatures on macrophage activity, researchers often simply increase temperature in cell cultures, or elevate body temperature by external heat application in murine models. While these procedures do not reproduce critical features of actual fevers, several studies reveal both *positive* ([@B29]; [@B57]; [@B43]) and *negative* ([@B16]; [@B17]; [@B23]) effects on macrophage pro-inflammatory cytokine production. Both positive and negative effects of hyperthermia have been correlated with an induction of heat shock proteins (HSPs). The overall aim of this brief review is to present previous studies that have studied the impact of hyperthermia and HSPs on macrophage functions and to summarize available information regarding the underlying molecular mechanisms which may mediate this complex interaction of thermal signals.

FEVER-RANGE TEMPERATURES CAN ENHANCE MACROPHAGE PRO-INFLAMMATORY CYTOKINE PRODUCTION
====================================================================================

Inducing hyperthermia has been used to study the role of febrile temperatures on the host defense system ([@B24]; [@B28]). It was shown that increasing core body temperature has a protective role in the outcome of infection; the improved survival seen was determined not to be simply due to thermal suppression of bacterial growth. Data published by our laboratory ([@B57]) as well as by others ([@B31]) shows that mild, systemic heating at a target temperature of 39.5°C significantly enhances the concentration of TNF-α (3-fold increase in sera; 2.5-fold increase in liver) and IL-6 (4-fold increase in sera; 2.6-fold increase in spleen, 3.4-fold in lung, and 15-fold in liver) in the blood and tissues of BALB/c mice challenged with bacteria endotoxin (LPS). In addition, [@B30] identified hepatic Kupffer cells as the predominant source of excess TNF-α secretion while multiple organs including lung, spleen, and liver could produce excess IL-6 in the warmer animals. These temperature-induced changes in cytokine expression are associated with an induction of HSP72 in the liver.

Our laboratory has recently observed that mild elevation of body temperature not only significantly enhances subsequent LPS-induced release of TNF-α (3-fold increase), but also reprograms macrophages, resulting in sustained subsequent responsiveness to LPS, i.e., this treatment reduces "endotoxin tolerance" *in vitro* and *in vivo* ([@B43]). Heat treatment results in an increase in LPS-induced downstream signaling including enhanced phosphorylation of IκB kinase (IKK) and IκB, NF-κB nuclear translocation and binding to the TNF-α promoter in macrophages upon secondary stimulation. The induction of HSP70 is important for mediation of thermal effects on macrophage function ([@B43]). Our *in vitro* experiments also show that the production of nitric oxide (NO) and inducible NO synthase (iNOS) by peritoneal macrophages is increased by exposure to febrile temperature together with LPS and IFN-γ stimulation. This result is correlated with the presence of HSP70 in the heat-treated macrophages ([@B60]). Collectively, these data suggest that fever-range hyperthermia can enhance macrophage cytokine expression and HSP70 expression, which in turn may help to improve host defense in response to infection.

FEVER-RANGE TEMPERATURES CAN ALSO SUPPRESS MACROPHAGE PRO-INFLAMMATORY CYTOKINE PRODUCTION
==========================================================================================

In contrast to the research summarized above, other studies using the macrophage cell lines RAW264.7 or human monocyte-derived macrophages have shown that hyperthermia has anti-inflammatory effects and suppresses activated macrophage pro-inflammatory cytokine expression (TNF-α, reduced by 50--98%; IL-6, reduced by 83--87%; and IL-1β, reduced by 50--94%; [@B16]; [@B17]; [@B23]). This inhibition is linked to a marked reduction in cytokine gene transcription and mRNA stability ([@B15]). In addition, this thermally suppressed cytokine production is mediated by the binding of heat shock factor (HSF)-1, a transcriptional repressor, to the heat shock response element in the cytokine promoter region, including IL-1β and TNF-α ([@B7]; [@B68]). Recently, [@B10],[@B11]) have shown that fever-range temperatures selectively reduce LPS-induced recruitment of NF-κB and Sp-1 transcription factors to the TNF-α promoter regions.

Heat-induced suppression may involve high mobility group box 1 (HMGB1), an intra-nuclear protein that can be released by activated macrophages, necrotic or damaged cells during inflammation. HMGB1 helps immune cells to recognize damaged tissues and initiates intracellular signaling to activate NF-κB and pro-inflammatory cytokine production ([@B19]). Hyperthermia has been shown to inhibit macrophage HMGB1 secretion following LPS stimulation ([@B17]) and [@B23] found that high fever temperature (40°C) enhances HSF-1 and HSP70 expression. These increased levels of HSF-1 and HSP70 may reduce HMGB1 secretion and subsequent NF-κB activation and cytokine production. In general, these data support the concept that febrile temperatures can also have inhibitory effects on macrophage cytokine gene expression, an effect correlated with the activation of HSF-1 or induction of HSP70.

REGULATION OF HEAT SHOCK PROTEINS
=================================

Heat shock proteins are evolutionarily conserved proteins that can be induced by stress signals, including environmental stresses (e.g., heat shock), and pathophysiological states (e.g., fever, inflammation, and infection) as well as those induced by normal development stresses ([@B50], [@B51]; [@B81]).

Heat shock proteins function as chaperones to assist with protein folding in order to protect cells from protein denaturation or cell death under stress conditions ([@B18]; [@B27]). Although HSPs are considered to be intracellular proteins, they can be mobilized to the plasma membrane or released into the extracellular environment and have immunomodulatory functions ([@B33]). HSPs (e.g., HSP60, HSP70, HSP90, gp96, etc.) can be released from various cells through either a passive (during cell injury) or an active (translocation to the plasma membrane and then secretion) pathway. Previous studies have shown that HSP70 is released into the extracellular environment in a membrane-associated form after heat stress ([@B53]; [@B77]). HSPs are known to have both positive and negative effects in regulating macrophage function *and this may depend on the cellular location of these HSPs*. It is proposed that extracellular HSPs might serve as a danger signal to stimulate the immune response, whereas intracellular HSPs could serve as a negative regulator to control the inflammation ([@B65]).

PRO-INFLAMMATORY ROLE OF HEAT SHOCK PROTEINS ON MACROPHAGE FUNCTION
===================================================================

Previous studies have shown that extracellular HSPs exert immunostimulatory effects ([@B33]). [@B80] have shown that extracellular HSP70 binds to the lipid raft microdomain on the plasma membrane of macrophages and enhances their phagocytic ability. This HSP70-mediated phagocytosis enhances the processing and presentation of internalized antigens to CD4 T cells. Furthermore, extracellular HSPs can robustly stimulate the release of TNF-α, IL-6, IL-1β, IL-12, NO, as well as chemokines by monocytes/macrophages ([@B44]; [@B2]; [@B58]; [@B77]). This effect is mediated through the CD14/TLR (both TLR2 and TLR4) complexes which lead to the activation of downstream NF-κB and MAPK pathway ([@B1]; [@B41]; [@B74]). In addition, HSPs are actively synthesized in peritoneal macrophages in mice which are administrated with LPS ([@B84]). HSP70 and HSP90 have been shown to be involved in the innate recognition of bacterial products. These HSPs are able to bind LPS and form a cluster with TLR4--MD2 within lipid raft to deliver LPS to the complex. Following stimulation, these HSPs further assist the trafficking and targeting of this complex to the Golgi apparatus ([@B72]; [@B73]). These results indicate that elevation of extracellular HSPs may serve as endogenous danger signals to alert the host defense system through their cytokine-like function.

ANTI-INFLAMMATORY ROLE OF HEAT SHOCK PROTEINS ON MACROPHAGE CYTOKINE EXPRESSION
===============================================================================

On the other hand, intracellular HSPs have been shown to have anti-inflammatory roles in suppressing macrophage cytokine production. Intracellular HSPs are involved in protecting the organism from a variety of insults by directly interfering with cell death pathway and suppressing the expression of inflammatory genes ([@B83]). The protect roles of stress-inducible intracellular HSPs (such as HSP72) in lethal sepsis and infection are well known. Induction of HSP70 *in vitro* by heat shock response or through overexpression can reduce mortality in experimental models of septic shock and endotoxemia as well as down-regulate inflammatory gene expression ([@B69]; [@B25]; [@B78]; [@B76]; [@B67]). It has been shown that intracellular HSP70 can interact with IKK, prevent IκB phosphorylation, and NF-κB activation ([@B61]). In addition, HSP70 is actively synthesized in macrophages after exposure to endotoxin. Intracellular HSP70 inhibits LPS-induced NF-κB activation by binding with TRAF6, the important adaptor protein downstream of TLR4 and preventing its ubiquitination ([@B8]). These results suggest that intracellular HSP70 may act as a suppressor to interfere NF-κB signaling and downstream inflammatory cytokine production. Furthermore, HSP72 has been shown to inhibit LPS- and TNF-α-induced HMGB1 release and subsequent pro-inflammatory cytokine production in macrophages ([@B71]).

On the other hand, there is only one study by [@B5] showing that hyperthermia (using target temperature 39, 41, and 43°C) inhibits LPS-stimulated IL-10 production by mononuclear cells isolated from healthy donor as compared to cells maintained at 43°C. In addition, by over-expressing HSP70 in human monocyte-derived macrophages, [@B14] found that LPS-induced IL-10 production was significantly inhibited. In our unpublished data, we tried to address whether fever-range temperature affects macrophage IL-10 production at different activation stages. However, we found that temperature did not have any effect on IL-10 expression by either naïve macrophages or previously activated macrophages. Taken together, these studies suggest that intracellular HSPs may exert negative regulatory effects to dampen the inflammatory response in order to prevent tissue damage.

HEAT SHOCK PROTEINS AND INFLAMMATORY DISORDERS
==============================================

There is some evidence that HSPs may play a role as immunological targets in chronic inflammatory diseases, such as RA ([@B75]) and atherosclerosis ([@B82]). Increased HSP60 and HSP70 expression have been identified in the synovial tissues from animals with experimental induced arthritis and patients with RA ([@B12]; [@B4]; [@B49]). Importantly, arthritis disease severity depends on the ability of human HSP60 and HSP70 to induce IL-10 production by monocytes/macrophages and fibroblast-like synoviocytes ([@B47]; [@B46]). The production of IL-10 is negatively correlated with arthritis progression and joint destruction ([@B26]; [@B70]). Several clinical trials in RA patients using immunotherapies involving HSPs have shown to promote anti-inflammatory cytokine production and ameliorate disease severity, indicating that HSPs have immunoregulatory potential ([@B79]; [@B64]; [@B59]).

On the other hand, HSP60 and HSP70 are also found in atherosclerotic lesions ([@B3]; [@B35]; [@B32]). During the past decade, it has been noted that infections (e.g., chlamydiae infection) might contribute to the pathogenesis of atherosclerosis to directly stimulate cells of the arterial wall and/or other tissues to express high levels of HSPs ([@B34]). Chlamydial HSP60 (cHSP60) colocalizes with human HSP60 within macrophages in atherosclerotic lesions ([@B42]). Both chlamydial and human HSPs stimulate the expression of pro-inflammatory cytokines and adhesion molecules by macrophages through TLR4/MD2-dependent pathway ([@B6]). Because of the high homology between chlamydial and human HSPs, it is possible that cross-reactions of antibodies and T cells against HSPs between microbes and humans contribute to the development of atherosclerosis ([@B82]). Taken together, a better understanding of the role of HSPs in the inflammatory process may lead to the development of new therapies to modify aberrant immune responses.

DOES THE MATURATION STATE OF MACROPHAGES INFLUENCE THE EFFECT OF HEAT AND HEAT SHOCK PROTEINS?
==============================================================================================

In this paper, we described previous studies revealing contrasting effects of febrile temperatures and HSPs on macrophage functions. Mild hyperthermia*enhances* macrophage TNF-α IL-6 as well as NO production in a HSP70/72-dependent mechanism. On the other hand, mild hyperthermia *suppresses* macrophage pro-inflammatory cytokine production and this may involve an increase in HSF-1 and HSP70 expression. Thermally induced HSF-1 and HSP70 also play a role in blocking the transcription factors NF-κB and Sp-1 recruitment to the cytokine promoter and subsequent cytokine secretion (see **Figure [1](#F1){ref-type="fig"}**, for possible pathways by which thermal stress may result in both pro- and anti-inflammatory effects).

![**Pro- and anti-inflammatory effects of heat and heat shock proteins**. Fever range temperature exerts both positive and negative effects on macrophage pro-inflammatory cytokine production. We proposed that these opposing effects may depend on the activation stage of macrophages as well as the cellular location of heat shock proteins. First, in the initiation phase of macrophage activation, fever range temperature enhances the production of LPS-induced pro-inflammatory cytokines TNF-α, IL-6, and NO. (1) This thermally enhanced cytokine production is associated with an induction of HSP70/72 in these cells. (2) HSP70 can then be released into the extracellular environment, and (3) exerts its cytokine effect through the CD14/TLR pathway. (4) This leads to the activation of NF-κB and MAPK pathway and subsequent cytokine gene transcription. On the other hand, fever-range temperature can also suppress LPS-induced TNF-α, IL-6, and IL-1β production and HMGB-1 release. (5) This is due to thermally induced HSF-1 binding directly to the heat shock response element in the cytokine promoter region and functions as a transcriptional repressor. (6) In addition, LPS and heat treatment can also induce HSP70 expression. HSP70 then binds to TRAF6 or IKK and inhibits subsequent NF-κB activation and cytokine production.](fimmu-03-00140-g001){#F1}

One possible explanation for these opposing results is that the resultant effect of heat is determined by the specific activation state of macrophages used for the analysis. For example, enhancing effects of heating were observed using cells freshly isolated from mice early after LPS injection ([@B30],[@B31]; [@B43]). These cells express a naïve phenotype. On the other hand, the suppressing effects were obtained using RAW264.7 cells which express an activated phenotype ([@B16]; [@B17]; [@B23]). Therefore, we propose that in cells associated with the early activation stage of inflammation, febrile temperature may stimulate macrophage cytokine production, which helps to eliminate invading pathogens, whereas if heat is applied to cells associated with the resolution phase, a suppression of macrophage cytokine production occurs to prevent further tissue damage. This idea, if correct, would suggest that one of the functions of natural fever may be to help resolve inflammation. Furthermore, to our knowledge, there is no previous study addressing the role of heat/HSP on alternatively activated macrophage functions. This indicates that more research is needed to identify the mechanistic basis of the contrasting effects of hyperthermia on macrophage function.

CONCLUSION
==========

The host inflammatory response to injury or infection is clearly a complex process. Pro-inflammatory cytokines secreted by activated macrophages are essential for successful host defense. However, uncontrolled inflammatory cytokine production will also cause tissue damage. The febrile response is a well recognized component of inflammation and has been shown to provide a beneficial effect for the host but whether the thermal element of fever has a direct role in regulating macrophage function is still not clear. By using hyperthermia, many studies have reported that febrile temperatures can regulate macrophage pro-inflammatory cytokine production both *in vitro* and *in vivo*. These effects are associated with the induction of HSP. However, these effects can be either positive or negative and much more research is needed to understand how these two contrasting effects coincide.

In addition, we also summarized research which shows both the pro- and anti-inflammatory roles of HSPs. Extracellular HSPs might serve as a danger signal to stimulate the immune response, whereas intracellular HSPs could serve as a negative regulator to control the inflammation. Studies of the roles and mechanisms of heat as well as HSPs in inflammatory disorders could provide more information for therapeutic strategies targeting the molecular levels.

Finally, it is important to remember that most of the research on the role of elevated temperature on macrophage function does not actually use a physiological fever (i.e., induced by endoxin or other pyrogens), but instead, simply forces the elevation of body temperature using external heating. While some studies described above do include the addition of LPS, or use heat in the presence of infectious antigens, fever involves many biochemical, neurological, and vascular changes not seen in conditions of forced hyperthermia ([@B37], [@B39]; [@B21]; [@B63], [@B62]). Therefore, it is possible that the elevated temperature associated with actual fever may have additional and more complex regulatory effects on macrophage function.
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